TABLE OF CONTENTS
Volume 5, Issue 3 (April 2008)
US Case Reports |
EU Case Reports |
US Legal and Regulatory Update |
EU Legal and Regulatory Update |
Patent Focus
Papers
Climate of change continues in Canada
Jim Keon
J Generic Med 5: 167-174; advance online publication, February 5, 2008; doi:10.1057/jgm.2008.1
Pricing strategies of originator and generic medicines following patent expiry in Belgium
Michael Adriaen, Kristof De Witte and Steven Simoens
J Generic Med 5: 175-187; advance online publication, March 6, 2008; doi:10.1057/jgm.2008.8
How to make the most of IP due diligence in deals involving generics
Beverly W Lubit
J Generic Med 5: 189-199; advance online publication, February 26, 2008; doi:10.1057/jgm.2008.5
The value of patent term extensions to the pharmaceutical industry in the USA FREE
Charles Clift
J Generic Med 5: 201-208; advance online publication, March 4, 2008; doi:10.1057/jgm.2008.6
Pharmacists' views on generic medicines: A review of the literature
Nabil Abdo Al-Gedadi and Mohamed Azmi Hassali
J Generic Med 5: 209-218; advance online publication, March 4, 2008; doi:10.1057/jgm.2008.7
US Case Reports
Aventis v Lupin: Obviousness of purified stereoisomers in view of mixtures thereof
Frederick H Rein and Joseph B Crystal
J Generic Med 5: 219-228; advance online publication, February 12, 2008; doi:10.1057/jgm.2008.2
EU Case Reports
Supplementary protection certificates; atorvastatin; fexofenadine
Michael Burdon, Robert Stephen, Priya Vatvani, Catherine Katzka and Luke Hill
J Generic Med 5: 229-233; advance online publication, February 11, 2008; doi:10.1057/jgm.2008.3
US Legal and Regulatory Update
Acarbose: A case study in the forfeiture of the 180-day exclusivity
Paul A Braier
J Generic Med 5: 235-240; advance online publication, March 11, 2008; doi:10.1057/jgm.2008.9
EU Legal and Regulatory Update
EU Legal and Regulatory Update
J Generic Med 5: 241-246; advance online publication, January 15, 2008; doi:10.1057/palgrave.jgm.4950105
